Deletion of Chromosome 4q Predicts Outcome in Stage II Colon Cancer Patients

Deletion of Chromosome 4q Predicts Outcome in Stage II Colon Cancer Patients

Background: Around 30% of all stage II colon cancer patients will relapse and die of their disease. At present no objective parameters to identify high-risk stage II colon cancer patients, who will benefit from adjuvant chemotherapy, have been established. With traditional histopathological features...

Full description

Bibliographic Details
Main Authors: R. P. M. Brosens, E. J. T. H. Belt, J. C. Haan, T. E. Buffart, B. Carvalho, H. Grabsch, P. Quirke, M. A. Cuesta, A. F. Engel, B. Ylstra, G. A. Meijer
Format: Article
Language:English
Published: Hindawi Limited 2010-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.3233/ACP-CLO-2010-0531

Internet

http://dx.doi.org/10.3233/ACP-CLO-2010-0531

Similar Items